Maddy summaryThe SHIELD Act of 2025 withholds federal funding from states or local governments that arrest, detain, or prosecute federal officers for lawful immigration enforcement actions. It directly affects jurisdictions (like cities or counties) that interfere with federal immigration enforcement, such as by blocking ICE operations. The law requires the Attorney General and DHS to determine violations, then blocks all federal grants and contracts for the affected jurisdiction during the fiscal year. Funding withheld is reallocated to compliant jurisdictions, and restoration requires written assurances that interference will stop.
Rep. Tim Burchett
Sponsored bills
Maddy summaryHR 6515 requires the federal government to establish a verification process within 60 days to check if the same Social Security number is used by multiple individuals enrolling in health insurance through federal or state Exchanges for the same coverage period. If duplicates are identified, it prevents duplicate payments of government premium tax credits (advance payments) for the same person. The bill directly affects individuals using health insurance Exchanges and the agencies managing those systems. It creates a concrete administrative mechanism to stop accidental overpayments of tax credits.
Maddy summaryThis bill requires the federal government to automatically identify people enrolled in both Medicaid/CHIP (free or low-cost public coverage) and a private health plan purchased through a health insurance marketplace (Exchange). It mandates quarterly data matching between Exchange enrollment records and Medicaid/CHIP records using the Public Assistance Reporting System (PARIS) within 60 days of enactment. If an individual is found enrolled in both programs, the government must stop providing them with premium tax credits or cost-sharing subsidies through the Exchange. The policy directly affects dual enrollees who would otherwise receive duplicate government health coverage subsidies.
Maddy summaryHR 6466, the Forced Abortion Prevention and Accountability Act, prohibits non-consensual administration of abortion drugs (like mifepristone or misoprostol) to pregnant women without their informed consent. It criminalizes this act with penalties up to 25 years in prison and allows victims to sue for triple damages, psychological/physical injury compensation, and attorney fees. The bill directly affects pregnant women who might face coerced procedures and medical providers or others who administer such drugs without consent. Key provisions include criminal penalties for the act itself, enhanced penalties for serious injury or death, and a civil remedy framework for victims seeking compensation.
Maddy summaryHR 6372, the D.C. Shield Law Repeal Act, repeals the Human Rights Sanctuary Amendment Act of 2022 (D.C. Law 24-257), which had modified District of Columbia protections for certain immigrant residents. The bill restores the previous legal framework that existed before the 2022 amendment took effect. This directly affects D.C. law and its implementation regarding immigrant rights within the District.
Maddy summaryHR 6393, the "DSH in Tennessee Act," permanently restores and guarantees specific federal hospital funding for Tennessee starting in fiscal year 2026. It directs the federal government to provide Tennessee with a Disproportionate Share Hospital (DSH) allotment equal to the state's 2015 level, adjusted annually for inflation based on the Consumer Price Index. This funding directly supports hospitals in Tennessee that serve large numbers of low-income patients, ensuring they receive consistent federal financial assistance. The bill treats Tennessee as a "low DSH state" for future funding calculations, establishing a permanent, inflation-adjusted funding formula.
Maddy summaryHR 5749, the Official Time Reporting Act, requires federal agencies to report annually on how they use "official time" - when union-represented employees perform union duties during work hours. Agencies must submit detailed data to the Office of Personnel Management (OPM) by December 31 each year, including total official time granted, costs, explanations for year-over-year increases, and specific activities covered. OPM then compiles this information into a public report by March 31, showing agency-level breakdowns and comparing data across years. This bill directly affects all federal agencies with union-represented employees, mandating transparency about official time usage and associated costs. The reporting aims to provide clear, standardized data for public accountability without changing existing official time policies.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
Maddy summaryHCONRES 58 is a symbolic congressional resolution denouncing socialism in all its forms. It does not create new laws or affect any policies, as it is a non-binding statement of opinion. The resolution cites historical events and quotes from Founding Fathers to argue that socialism leads to authoritarianism and economic harm, referencing examples like the Soviet Union and Venezuela. It formally "denounces" socialism and opposes implementing socialist policies in the U.S., but has no legal effect on citizens or government actions. This is a procedural resolution, not a policy measure.
Maddy summaryHR 5565, the "Make Federal Architecture Beautiful Again Act," requires the General Services Administration (GSA) to prioritize classical and traditional architectural styles (such as Neoclassical, Georgian, or Beaux-Arts) for certain federal buildings. It directly affects GSA in designing, building, or renovating courthouses, agency headquarters, and other federal buildings costing over $50 million (in 2025 dollars), excluding infrastructure. Key mechanisms include mandating GSA to update policies to favor these styles, require GSA architects to have classical/traditional expertise, create a dedicated classical architecture advisor role, and ensure design competitions prioritize firms with relevant experience. The bill also requires GSA to notify the President 30 days in advance if approving a non-preferred design (like Brutalist or Deconstructivist architecture), providing detailed justification and cost comparisons.